This article first appeared on Forbes.com Speed to market has always been critical in the life sciences industry. Companies that bring products to market quickly and efficiently are better positioned to succeed and improve patient outcomes. Or so the industry wisdom goes. For Moderna, the covid wunderkind that captured almost $40 billion in sales over the […]
Optimizing How R&D Dollars are Spent | Ross Muken, CFO, Sophia Genetics
GUEST CFO: Ross Muken of Sophia Genetics EPISODE: #842: Realizing the Potential of Data at Scale
738: Using Digital Insight to Unlock Business Value | Sameer Ralhan, CFO, The Chemours Company
Unlike many of the up-and-comers who populate the corridors of The Chemours Company, CFO Sameer Ralhan spent the balance of his career-building years with the company inside its manufacturing plants. It was there where Ralhan says that he observed everyday executives making decisions that routinely impacted the business, and it was there where his M&A…
Listen to the Episode Below (00:48:54)